Natera · 5 hours ago
Senior Scientist, R&D
San Carlos, CA
Full-time
Onsite
Senior Level
$138K/yr - $177K/yr
5+ years expNatera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. The Senior Scientist will join the Molecular Biology Research team to plan, design, and execute laboratory research for advancing Natera's liquid biopsy product portfolio.
BiotechnologyGeneticsHealth DiagnosticsMedicalWomen's
Responsibilities
Contributes intellectually and creatively to research and development planning and innovation
Leads Oncology projects to create and develop novel nucleic acid based diagnostic tests; including planning, feasibility testing, protocol development, feasibility, optimization, and transfer to Development
Responsible for project-associated timeline and deliverable planning and management
Thoroughly comprehends the objectives and vision of the work
Independently develops plans, generates and advances new ideas
Independently designs and executes high complexity experiments
Coordinates the execution and analysis of effective experiments with statistics and bioinformatics teams
Performs basic data analysis (e.g. R, JMP, Excel)
May manage research associates
Very strong communication, analytical and problem-solving skills
Documents research progress under a Quality Management System
Actively interacts and communicates with interdepartmental teams such as SciOps, Program Management, Bioinformatics, Data Science, Engineering, Translational Science, and Product
Communicates progress directly with manager and colleagues
Employee must complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training and security training as soon as possible but not later than the first 30 days of hire
Must maintain a current status on Natera training requirements
Perform other duties as assigned
Qualification
Required
Ph.D. with a minimum of 5 - 8 years of industry experience or 2+ years post-doctoral research and 3+ years of industry experience
Must have extensive experience designing, executing, analyzing data and problem solving of next generation sequencing (NGS) and DNA molecular biology experiments
Track record of originating, developing and productizing novel nucleic acid and multiomic techniques and tests
Strong research skills with a history of innovation and scientific accomplishment
Must have excellent communication, organizational, record-keeping, planning, time management and analytical skills
Experience managing and providing basic leadership to research associates and junior scientists
Demonstrated success in applying independent scientific judgment in experimental design and analysis
Skilled at writing clear plans, reports and SOPs
Preferred
Cancer research experience is desired
Experience with approaches such as: epigenetic/methylation analysis, target capture/enrichment, WGS
cfDNA experience is a plus
Experience with automation is a plus
Bioinformatic capabilities, programming (e.g. python) and database experience (SQL) are a plus
Benefits
Annual performance incentive bonus
Long-term equity awards
Comprehensive health benefits (medical, dental, vision)
401(k) with company match
Generous paid time off and company holidays
Additional wellness and work-life benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
5001-10000 employees
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Leadership Team
Steve Chapman
CEO
Jonathan Sheena
Co-Founder, Board Member
Recent News
2026-01-22
Business Wire
2026-01-22
Company data provided by crunchbase